Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient
- PMID: 8319713
- DOI: 10.1007/BF01955905
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient
Abstract
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD), the third enzyme of the mitochondrial beta-oxidation pathway, carries out the dehydrogenation of 3-hydroxyacyl-CoA compounds of 12-18 carbon length. To date only nine cases of LCHAD deficiency have been documented. We report a further patient who as a neonate developed non-specific gastrointestinal symptoms and at 5 months of age cardiomyopathy, recurrent hypoketotic hypoglycaemia and gross alterations of plasma carnitine fractions. Dietary management with medium chain triglycerides led rapidly to clinical improvement. There was a close correlation between the clinical condition, plasma carnitine fractions and cardiac function. At 2 years of age she is developing normally.
Similar articles
-
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.Eur J Pediatr. 1994 Oct;153(10):745-50. doi: 10.1007/BF01954492. Eur J Pediatr. 1994. PMID: 7813533 Review.
-
Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?Acta Paediatr. 2005 Jan;94(1):48-52. doi: 10.1111/j.1651-2227.2005.tb01787.x. Acta Paediatr. 2005. PMID: 15858960
-
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients.J Pediatr. 1997 Jan;130(1):67-76. doi: 10.1016/s0022-3476(97)70312-3. J Pediatr. 1997. PMID: 9003853
-
Acute fatty liver of pregnancy and neonatal long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency.Eur J Pediatr. 2009 Jan;168(1):103-6. doi: 10.1007/s00431-008-0696-z. Epub 2008 Apr 12. Eur J Pediatr. 2009. PMID: 18408953
-
The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.Pediatr Neurol. 1996 Apr;14(3):236-43. doi: 10.1016/0887-8994(96)00021-5. Pediatr Neurol. 1996. PMID: 8736409 Review.
Cited by
-
What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?J Inherit Metab Dis. 2003;26(4):353-60. doi: 10.1023/a:1025107119186. J Inherit Metab Dis. 2003. PMID: 12971423
-
Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.Mol Genet Metab. 2012 Jan;105(1):110-5. doi: 10.1016/j.ymgme.2011.09.030. Epub 2011 Oct 1. Mol Genet Metab. 2012. PMID: 22030098 Free PMC article. Clinical Trial.
-
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.Eur J Pediatr. 1994 Oct;153(10):745-50. doi: 10.1007/BF01954492. Eur J Pediatr. 1994. PMID: 7813533 Review.
-
Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.J Inherit Metab Dis. 2000 Sep;23(6):571-82. doi: 10.1023/a:1005673828469. J Inherit Metab Dis. 2000. PMID: 11032332
-
Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):169-76. doi: 10.1136/jnnp.62.2.169. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048718 Free PMC article.